The Translational Research Institute (TRI) Australia, a unique model for collaboration and commercialisation, is developing a new generation of scientists who can work with industry to transform Australia’s international competitiveness in medical research.
Home to around 800 researchers, clinicians and support staff, and over 1,000 students, it was formed through the collaboration of The University of Queensland, the Queensland University of Technology, Mater Research and Metro South Health, part of Queensland Health.
The seven-story TRI building is located adjacent to the Princess Alexandra Hospital and incorporates four floors of state-of-the-art laboratories, facilities for research support, and administration and teaching; while its Clinical Research Facility, located at the hospital, enables human trials of new drugs and therapies. TRI is an award-winning facility with world-leading researchers who are focussed on translating their discoveries.
It demonstrates Australia’s commitment to being an important player on a global scale; and to building a knowledge economy and retaining some of the financial benefits of commercialising a diagnostic paradigm, therapy or treatment. TRI is conceived as a series of interconnected places to enable a collaborative approach to medical research. From the intimate to the expansive, the building acknowledges the diverse communities that occupy the facility. It supports the intensity of scientific research and extends the opportunities for ongoing collaborations.
Atrium and selected floors of the Institute
Sunday Guided Tours
Times: Join architects Damian Eckersley and Michael Hartwich for guided tours on the hour